Alyeska Investment Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,329,420
| Closed | -$29M | – | 606 |
|
|
2024
Q4 | $29M | Buy |
5,329,420
+3,161,072
| +146% | +$17.2M | 0.11% | 218 |
|
|
2024
Q3 | $18M | Buy |
2,168,348
+4,465
| +0.2% | +$37.1K | 0.09% | 244 |
|
|
2024
Q2 | $15.5M | Buy |
2,163,883
+27,394
| +1% | +$196K | 0.09% | 234 |
|
|
2024
Q1 | $18.5M | Sell |
2,136,489
-1,060,000
| -33% | -$9.19M | 0.11% | 216 |
|
|
2023
Q4 | $20.9M | Buy |
3,196,489
+810,742
| +34% | +$5.31M | 0.14% | 195 |
|
|
2023
Q3 | $23.9M | Sell |
2,385,747
-90,000
| -4% | -$900K | 0.16% | 182 |
|
|
2023
Q2 | $30.8M | Buy |
2,475,747
+691,686
| +39% | +$8.6M | 0.23% | 141 |
|
|
2023
Q1 | $25M | Buy |
1,784,061
+535,242
| +43% | +$7.5M | 0.22% | 136 |
|
|
2022
Q4 | $17.9M | Sell |
1,248,819
-360,753
| -22% | -$5.16M | 0.18% | 161 |
|
|
2022
Q3 | $41.1M | Buy |
1,609,572
+586,041
| +57% | +$15M | 0.48% | 70 |
|
|
2022
Q2 | $29.1M | Buy |
1,023,531
+147,384
| +17% | +$4.19M | 0.33% | 96 |
|
|
2022
Q1 | $30.9M | Buy |
+876,147
| New | +$30.9M | 0.34% | 102 |
|
|
2021
Q4 | – | Sell |
-440,046
| Closed | -$21.6M | – | 688 |
|
|
2021
Q3 | $21.6M | Buy |
+440,046
| New | +$21.6M | 0.27% | 109 |
|
|
2021
Q2 | – | Sell |
-123,764
| Closed | -$4.41M | – | 788 |
|
|
2021
Q1 | $4.41M | Sell |
123,764
-936,644
| -88% | -$33.4M | 0.06% | 341 |
|
|
2020
Q4 | $29.7M | Buy |
+1,060,408
| New | +$29.7M | 0.42% | 66 |
|